In just a decade, the drug-resistant fungal pathogen Candida auris (C. auris) has emerged as one of the most formidable threats to health care settings worldwide.
Clinical cases of Candida auris jumped more than 50% from 2022 to 2023, according to state data reported to the CDC.
A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback